Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: E9ACZ0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003723 | RNA binding | 4 | 3 |
GO:0005488 | binding | 1 | 17 |
GO:0043167 | ion binding | 2 | 17 |
GO:0043169 | cation binding | 3 | 17 |
GO:0046872 | metal ion binding | 4 | 17 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.507 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.260 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.489 |
DOC_MAPK_gen_1 | 103 | 112 | PF00069 | 0.474 |
DOC_PP4_MxPP_1 | 46 | 49 | PF00568 | 0.433 |
DOC_USP7_MATH_1 | 17 | 21 | PF00917 | 0.448 |
DOC_USP7_UBL2_3 | 105 | 109 | PF12436 | 0.437 |
LIG_14-3-3_CanoR_1 | 136 | 142 | PF00244 | 0.635 |
LIG_APCC_ABBA_1 | 110 | 115 | PF00400 | 0.277 |
LIG_APCC_ABBAyCdc20_2 | 109 | 115 | PF00400 | 0.277 |
LIG_FHA_2 | 76 | 82 | PF00498 | 0.528 |
LIG_Integrin_isoDGR_2 | 86 | 88 | PF01839 | 0.643 |
LIG_LIR_Apic_2 | 70 | 76 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 78 | 83 | PF02991 | 0.509 |
LIG_MYND_1 | 45 | 49 | PF01753 | 0.302 |
LIG_Pex14_1 | 51 | 55 | PF04695 | 0.303 |
LIG_SH2_GRB2like | 83 | 86 | PF00017 | 0.540 |
LIG_SH2_SRC | 63 | 66 | PF00017 | 0.338 |
LIG_SH2_STAT3 | 40 | 43 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 63 | 66 | PF00017 | 0.302 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.514 |
LIG_SUMO_SIM_anti_2 | 22 | 29 | PF11976 | 0.479 |
LIG_SUMO_SIM_par_1 | 22 | 29 | PF11976 | 0.479 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.478 |
MOD_CK2_1 | 75 | 81 | PF00069 | 0.521 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.543 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.479 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.367 |
MOD_N-GLC_1 | 29 | 34 | PF02516 | 0.471 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.459 |
MOD_PIKK_1 | 137 | 143 | PF00454 | 0.575 |
MOD_PIKK_1 | 17 | 23 | PF00454 | 0.449 |
MOD_Plk_1 | 29 | 35 | PF00069 | 0.472 |
MOD_SUMO_rev_2 | 54 | 61 | PF00179 | 0.394 |
TRG_ER_diArg_1 | 8 | 10 | PF00400 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4E5 | Leptomonas seymouri | 83% | 100% |
A0A0S4IT37 | Bodo saltans | 47% | 100% |
A0A1X0NLL7 | Trypanosomatidae | 56% | 100% |
A0A3R7NZE2 | Trypanosoma rangeli | 55% | 100% |
A0A3S7X0B7 | Leishmania donovani | 96% | 99% |
A0A3S7X5L3 | Leishmania donovani | 47% | 100% |
A4HFD2 | Leishmania braziliensis | 94% | 100% |
A4HKG1 | Leishmania braziliensis | 46% | 100% |
A4I363 | Leishmania infantum | 96% | 99% |
A4I7Y9 | Leishmania infantum | 47% | 100% |
C9ZKV1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 100% |
D0AA56 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AYR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
E9B2V0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 47% | 100% |
Q4Q5A6 | Leishmania major | 49% | 100% |